Argus raises target to USD 284 for Tenet Healthcare stock

Published on 10/15/2026 at 13:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Tenet booked USD 5.60 billion in revenue in the second quarter of 2026. Tenet Healthcare stock costs EUR 244.00 on October 15, 2026.

Target and operating evidence

Argus lifted its Tenet target to USD 284 on October 14, 2026.
Second-quarter adjusted EBITDA reached USD 1.304 billion at a 23.2 percent margin.
Tenet Healthcare stock was trading at EUR 244.00 at 1:35 p.m. CEST at Lang & Schwarz on October 15, 2026.

THC, US88033G4073, Illustration mit AI erstellt.

Tenet Healthcare (ISIN US88033G4073) was trading at EUR 244.00 at Lang & Schwarz on October 15, 2026 at 1:35 p.m. CEST. On October 14, 2026, Argus raised its target for the hospital and ambulatory-care operator to USD 284, as Simply Wall St reported.

Target reflects operating progress

The target change follows a strong second quarter. Tenet reported USD 5.60 billion in net operating revenue and USD 1.304 billion in adjusted EBITDA for the second quarter of 2026, with an adjusted EBITDA margin of 23.2 percent, according to Fortune.

Ambulatory care remained a key contributor. United Surgical Partners International generated USD 542 million in adjusted EBITDA in the second quarter, up 8.8 percent from the second quarter of 2025, while the hospital segment produced USD 762 million, up 22 percent year over year, according to the same earnings-call report.

What does the target imply?

Argus's USD 284 target places valuation expectations above the current euro quote, but the currencies cannot be compared directly. The operating figures provide the more useful test: Tenet's second-quarter adjusted EBITDA growth and 23.2 percent margin show why outpatient care and cost control remain central to the valuation case.

Three recent reference points

On July 23, 2026, Tenet reported second-quarter earnings per share of USD 6.12 against a USD 4.26 consensus estimate, according to MarketBeat. On September 23, 2026, the earnings-call report detailed second-quarter adjusted EBITDA of USD 1.304 billion. On October 14, 2026, Argus raised its target to USD 284.

Next date for investors

Tenet is scheduled to report third-quarter 2026 results before the market opens on October 29, 2026, with its conference call set for 10:00 a.m. ET, according to MarketBeat. Consensus calls for USD 5.49 billion in revenue and USD 4.67 in earnings per share for that quarter.

Price stays central to the setup

The next results will test whether Tenet can extend the margin and earnings gains that supported the latest target increase. The stock was trading at EUR 244.00 at Lang & Schwarz on October 15, 2026 at 1:35 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Tenet Healthcare stock.